Francesco Saverio Ragusa

Dr. Francesco Saverio Ragusa

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Ligia DominguezLigia Dominguez
Ligia Dominguez
Nicola VeroneseNicola Veronese
Nicola Veronese
Lee SmithLee Smith
Lee Smith
Francesco Saverio RagusaFrancesco Saverio Ragusa
Francesco Saverio Ragusa
PSPIERO SCHIRO'
PIERO SCHIRO'
MBMARIO BARBAGALLO
MARIO BARBAGALLO
The loss of skeletal muscle mass and strength, known as sarcopenia, is prevalent in older adults and linked to an increased risk of disability, frailty, and early mortality. Muscle health is crucial for the functionality and independence of older adults. As the aging population continuously grows, finding cost-effective strategies for preventing and treating sarcopenia is an important public health priority. While nutrition is recognized as a key factor in the development of sarcopenia, its role in preventing and treating the condition is still under investigation. In recent decades, nutritional research has shifted from a focus on individual nutrients or healthy foods to examining the combination of nutrients and foods in dietary patterns, along with their potential synergistic and antagonistic effects. A balanced diet and regular participation in physical activity are essential for maintaining musculoskeletal health. One of the healthy eating patterns with the greatest evidence of multiple health benefits is the Mediterranean diet, which has also been linked to positive effects on muscle function in observational studies. However, there is a lack of intervention studies. This review explores the updated evidence from longitudinal prospective studies on associations between adherence to the Mediterranean diet and sarcopenia in order to promote preventive and intervention strategies for healthy muscle aging.

25 August 2023 in Archives of Gerontology and Geriatrics
Verified
Journal Article
Open access
LMLaura Maniscalco
Laura Maniscalco
Nicola VeroneseNicola Veronese
Nicola Veronese
Francesco Saverio RagusaFrancesco Saverio Ragusa
Francesco Saverio Ragusa
LVLaura Vernuccio
Laura Vernuccio
LDLigia J. Dominguez
Ligia J. Dominguez
MBMario Barbagallo
Mario Barbagallo
Literature on the association between sarcopenia and cognitive impairment is largely unclear and mainly limited to non-European populations. Therefore, the aim of this study is to explore if the presence of sarcopenia at the baseline could increase the risk of cognitive impairment in a large cohort of older people participating to the English Longitudinal Study of Ageing (ELSA), over ten years of follow-up. Sarcopenia was diagnosed as having low handgrip strength and low skeletal muscle mass index at the baseline, using a muscle mass prediction model; cognitive function was evaluated in the ELSA through several tests. The results are reported in the whole sample adjusted for potential baseline confounders and after matching sarcopenic and non-sarcopenic participants with a propensity score. 2738 people (mean age: 68.7 years, 54.4% males) were included. During the ten years of follow-up, sarcopenia was associated with significantly lower scores in memory (p < 0.001), verbal fluency (p < 0.001), immediate word recall (p <0.001), delayed word recall (p = 0.018), and in recall summary score (p < 0.001). After adjusting for eight potential confounders, the presence of sarcopenia was significantly associated with poor verbal fluency (odds ratio, OR= 1.417, 95% confidence intervals, CI= 1.181-1.700) and in propensity-score matched analyses (OR=1.272, 95%CI= 1.071- 1.511). Sarcopenia was found to be associated with a significantly higher incidence of poor cognitive status in a large population of elderly people followed up for 10 years, suggesting it may be an important potential risk factor for dementia.

10 June 2024 in Aging Clinical and Experimental Research
Verified
Journal Article
Open access
PDF file
Francesco Saverio RagusaFrancesco Saverio Ragusa
Francesco Saverio Ragusa
Nicola VeroneseNicola Veronese
Nicola Veronese
LVLaura Vernuccio
Laura Vernuccio
LDLigia J Dominguez
Ligia J Dominguez
LSLee Smith
Lee Smith
MBMario Barbagallo
Mario Barbagallo
Background: Mild cognitive impairment (MCI) and sarcopenia are two common conditions in older people. It is not widely known if MCI could predict the onset of sarcopenia. Therefore, we aimed to investigate whether MCI could predict the occurrence of sarcopenia in a population of older adults. Methods: In the ELSA (English Longitudinal Study on Ageing), MCI was defined as the absence of dementia, preserved functional capacity and low performance in three objective cognitive tests. Sarcopenia was diagnosed as having low handgrip strength and low skeletal muscle mass index during follow-up. The longitudinal association between MCI at the baseline and incident sarcopenia was assessed using a multivariable logistic regression model, reporting the data as adjusted odds ratios (OR) and 95% confidence intervals (95%CI). Results: 3,106 participants (mean age of 63.1 years; 55.3% males) were included. People with MCI reported significantly lower mean handgrip strength values and Skeletal Mass Index (SMI), as well as a higher prevalence of obesity at baseline. At baseline, 729 people had MCI and during the ten years follow-up period, 12.1% of the initial population included had sarcopenia. On multivariate analysis, adjusted for 18 potential confounders, the presence of MCI (OR = 1.236; 95%CI: 1.090–1.596, p = 0.01) significantly predicted the onset of sarcopenia during follow-up. Conclusion: The presence of MCI at baseline was associated with a higher incidence of sarcopenia at ten-years follow-up, demonstrating a likely role of MCI as a predictor of the onset of sarcopenia in older people.

28 July 2025 in Aging Clinical and Experimental Research
Verified
Journal Article
Open access
Francesco Saverio RagusaFrancesco Saverio Ragusa
Francesco Saverio Ragusa
TTToshiko Tanaka
Toshiko Tanaka
NVNicola Veronese
Nicola Veronese
PMPasquale Mansueto
Pasquale Mansueto
LDLigia J. Dominguez
Ligia J. Dominguez
LFLuigi Ferrucci
Luigi Ferrucci
Obesity and aging are interrelated public health concerns, with growing prevalence, especially as global demographics shift toward an older population. This narrative review explores the mechanisms through which obesity accelerates the aging process, focusing on major aging pathways affected by obesity, including deregulated nutrient sensing, telomeres attrition, epigenetic alterations, mitochondrial dysfunction, stem cell exhaustion, and altered intercellular communication. Evidence suggests that these disruptions not only drive age-related diseases, such as cardiovascular disease, type 2 diabetes, and neurodegenerative conditions, but also exacerbate mobility limitations, cognitive decline, and reduced quality of life in older adults. The role of lifestyle interventions, particularly adherence to the Mediterranean diet, is emphasized for its anti-inflammatory and metabolic benefits, alongside strategies to address the social and psychological impacts of obesity on aging. By recognizing obesity as a significant modifiable risk factor for accelerated aging, this review advocates comprehensive and targeted interventions to promote healthier aging and improve quality of life in older populations globally.

25 March 2023 in Aging Clinical and Experimental Research
Verified
Journal Article
Open access
PDF file
Francesco Saverio RagusaFrancesco Saverio Ragusa
Francesco Saverio Ragusa
LSLuisa Solimando
Luisa Solimando
CMCaterina Mandalà
Caterina Mandalà
RMRoberta Masnata
Roberta Masnata
GCGregorio Ciulla
Gregorio Ciulla
MBMario Barbagallo
Mario Barbagallo
Background Only limited studies analyzed a possible relationship between frailty and infections. Our aim was to investigate the possible association between higher multidimensional prognostic index (MPI) values, a tool for evaluating multidimensional frailty, and the prevalence of infectious diseases, including antibiotics’ cost and the prevalence of MDR (multidrug resistance) pathogens. Methods Older patients, affected by COVID-19, were enrolled in the hospital of Palermo over four months. Results 112 participants (mean age 77.6, 55.4% males) were included. After adjusting for potential confounders, frailer participants had a higher odds of any positivity to pathogens (prevalence: 61.5%, odds ratio = 15.56, p < 0.0001) compared to a prevalence of 8.6% in more robust, including MDR, and a higher costs in antibiotics. Conclusions Higher MPI values, indicating frailer subjects, were associated with a higher prevalence of infections, particularly of MDR pathogens, and a consequent increase in antibiotics’ cost.

14 May 2026 in Health Economics Review
Verified
Journal Article
Open access
PDF file
APAlberto Pilotto
Alberto Pilotto
Francesco Saverio RagusaFrancesco Saverio Ragusa
Francesco Saverio Ragusa
NVNicola Veronese
Nicola Veronese
CCCarlo Custodero
Carlo Custodero
PTPascal Roberto Titone
Pascal Roberto Titone
MHMickaël Hiligsmann
Mickaël Hiligsmann
The role of Comprehensive Geriatric Assessment (CGA) is crucial from a clinical point of view for frail older patients, permitting tailored interventions t